September 19, 2014 12:44 AM ET

Pharmaceuticals

Company Overview of Collegium Pharmaceutical, Inc.

Executive Profile

Michael T. Heffernan B.S. Pharm, R.Ph.

Co-Founder, Chief Executive Officer, President and Director, Collegium Pharmaceutical, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 8 different industries.

See Board Relationships
49--

Background

Mr. Michael T. Heffernan, also known as Mike, RPh, B.S. Pharm., co-founded Collegium Pharmaceutical, Inc. in 2002 and has been its Chief Executive Officer and President since 2002. Mr. Heffernan has been Senior Medical Advisor to Advocacy and Medical Education Efforts at Eli Lilly and Company since January 2013. He served as Chief Executive Officer and President of Clinical Studies Ltd. (CSL) from 1995 to 1999. He is a proven entrepreneur and senior level executive with ...

Corporate Headquarters

780 Dedham Street
Canton, Massachusetts 02021

United States

Phone: 781-713-3699
Fax: --

Board Members Memberships

Director
Co-Founder, Chief Executive Officer, President and Director
Director
1998-Present
Chairman of the Board
2002-Present
Director and Member of Compensation Committee
2008-Present
Director, Chairman of Compensation Committee, Member of Investment Committee and Member of Special Committee
2012-Present
Chairman of the Board, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education

BS
University of Connecticut

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Collegium Pharmaceutical, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.